+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Vaccine Research Market 2023-2027

  • PDF Icon

    Report

  • 160 Pages
  • July 2023
  • Region: Global
  • TechNavio
  • ID: 5606360
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vaccine research market is forecasted to grow by USD 17.59 bn during 2022-2027, accelerating at a CAGR of 9.88% during the forecast period. The report on the vaccine research market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of infectious diseases, need for novel vaccines for chronic infections, and adjuvants and vaccine delivery systems.

The vaccine research market is segmented as below:

By End-user

  • Public
  • Private

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the adoption of ai to speed up the R and D of vaccines as one of the prime reasons driving the vaccine research market growth during the next few years. Also, fluctuations in demand for vaccines in high-income and developing countries and rising R and D of novel vaccines will lead to sizable demand in the market.

The report on the vaccine research market covers the following areas:

  • Vaccine research market sizing
  • Vaccine research market forecast
  • Vaccine research market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccine research market vendors that include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Creative Biogene. Also, the vaccine research market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Age Group
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global vaccine research market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global vaccine research market 2017 - 2021 ($ billion)
4.2 End-User Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-User Segment 2017 - 2021 ($ billion)
4.3 Age Group Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Age Group Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Public - Market size and forecast 2022-2027
Exhibit 34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Public - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Public - Year-over-year growth 2022-2027 (%)
6.4 Private - Market size and forecast 2022-2027
Exhibit 38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Private - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Private - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by End-user
Exhibit 42: Market opportunity by End-user ($ billion)
Exhibit 43: Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Age Group
7.1 Market segments
Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)
7.2 Comparison by Age Group
Exhibit 46: Chart on Comparison by Age Group
Exhibit 47: Data Table on Comparison by Age Group
7.3 Pediatric - Market size and forecast 2022-2027
Exhibit 48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
Exhibit 50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
7.4 Adult - Market size and forecast 2022-2027
Exhibit 52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Adult - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Adult - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Age Group
Exhibit 56: Market opportunity by Age Group ($ billion)
Exhibit 57: Data Table on Market opportunity by Age Group ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 Astellas Pharma Inc.
Exhibit 112: Astellas Pharma Inc. - Overview
Exhibit 113: Astellas Pharma Inc. - Product/Service
Exhibit 114: Astellas Pharma Inc. - Key news
Exhibit 115: Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 116: AstraZeneca Plc - Overview
Exhibit 117: AstraZeneca Plc - Product/Service
Exhibit 118: AstraZeneca Plc - Key news
Exhibit 119: AstraZeneca Plc - Key offerings
12.6 Bavarian Nordic AS
Exhibit 120: Bavarian Nordic AS - Overview
Exhibit 121: Bavarian Nordic AS - Product/Service
Exhibit 122: Bavarian Nordic AS - Key offerings
12.7 Bharat Biotech Ltd.
Exhibit 123: Bharat Biotech Ltd. - Overview
Exhibit 124: Bharat Biotech Ltd. - Product/Service
Exhibit 125: Bharat Biotech Ltd. - Key news
Exhibit 126: Bharat Biotech Ltd. - Key offerings
12.8 CanSino Biologics Inc.
Exhibit 127: CanSino Biologics Inc. - Overview
Exhibit 128: CanSino Biologics Inc. - Product/Service
Exhibit 129: CanSino Biologics Inc. - Key offerings
12.9 CSL Ltd.
Exhibit 130: CSL Ltd. - Overview
Exhibit 131: CSL Ltd. - Business segments
Exhibit 132: CSL Ltd. - Key news
Exhibit 133: CSL Ltd. - Key offerings
Exhibit 134: CSL Ltd. - Segment focus
12.10 Daiichi Sankyo Co. Ltd.
Exhibit 135: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 136: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibit 137: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 138: Daiichi Sankyo Co. Ltd. - Key offerings
12.11 Emergent BioSolutions Inc.
Exhibit 139: Emergent BioSolutions Inc. - Overview
Exhibit 140: Emergent BioSolutions Inc. - Product/Service
Exhibit 141: Emergent BioSolutions Inc. - Key news
Exhibit 142: Emergent BioSolutions Inc. - Key offerings
12.12 GlaxoSmithKline Plc
Exhibit 143: GlaxoSmithKline Plc - Overview
Exhibit 144: GlaxoSmithKline Plc - Business segments
Exhibit 145: GlaxoSmithKline Plc - Key news
Exhibit 146: GlaxoSmithKline Plc - Key offerings
Exhibit 147: GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Exhibit 148: Johnson and Johnson Services Inc. - Overview
Exhibit 149: Johnson and Johnson Services Inc. - Business segments
Exhibit 150: Johnson and Johnson Services Inc. - Key news
Exhibit 151: Johnson and Johnson Services Inc. - Key offerings
Exhibit 152: Johnson and Johnson Services Inc. - Segment focus
12.14 Merck and Co. Inc.
Exhibit 153: Merck and Co. Inc. - Overview
Exhibit 154: Merck and Co. Inc. - Business segments
Exhibit 155: Merck and Co. Inc. - Key news
Exhibit 156: Merck and Co. Inc. - Key offerings
Exhibit 157: Merck and Co. Inc. - Segment focus
12.15 Novavax Inc.
Exhibit 158: Novavax Inc. - Overview
Exhibit 159: Novavax Inc. - Product/Service
Exhibit 160: Novavax Inc. - Key offerings
12.16 Panacea Biotec Ltd.
Exhibit 161: Panacea Biotec Ltd. - Overview
Exhibit 162: Panacea Biotec Ltd. - Product/Service
Exhibit 163: Panacea Biotec Ltd. - Key offerings
12.17 Pfizer Inc.
Exhibit 164: Pfizer Inc. - Overview
Exhibit 165: Pfizer Inc. - Product/Service
Exhibit 166: Pfizer Inc. - Key news
Exhibit 167: Pfizer Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global vaccine research market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - End-User Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Age Group Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Public - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Public - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Private - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Private - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by End-user ($ billion)
Exhibits 43: Data Table on Market opportunity by End-user ($ billion)
Exhibits 44: Chart on Age Group - Market share 2022-2027 (%)
Exhibits 45: Data Table on Age Group - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Age Group
Exhibits 47: Data Table on Comparison by Age Group
Exhibits 48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
Exhibits 49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
Exhibits 50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
Exhibits 53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
Exhibits 54: Chart on Adult - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Adult - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Age Group ($ billion)
Exhibits 57: Data Table on Market opportunity by Age Group ($ billion)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ billion)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Abbott Laboratories - Overview
Exhibits 108: Abbott Laboratories - Business segments
Exhibits 109: Abbott Laboratories - Key news
Exhibits 110: Abbott Laboratories - Key offerings
Exhibits 111: Abbott Laboratories - Segment focus
Exhibits 112: Astellas Pharma Inc. - Overview
Exhibits 113: Astellas Pharma Inc. - Product/Service
Exhibits 114: Astellas Pharma Inc. - Key news
Exhibits 115: Astellas Pharma Inc. - Key offerings
Exhibits 116: AstraZeneca Plc - Overview
Exhibits 117: AstraZeneca Plc - Product/Service
Exhibits 118: AstraZeneca Plc - Key news
Exhibits 119: AstraZeneca Plc - Key offerings
Exhibits 120: Bavarian Nordic AS - Overview
Exhibits 121: Bavarian Nordic AS - Product/Service
Exhibits 122: Bavarian Nordic AS - Key offerings
Exhibits 123: Bharat Biotech Ltd. - Overview
Exhibits 124: Bharat Biotech Ltd. - Product/Service
Exhibits 125: Bharat Biotech Ltd. - Key news
Exhibits 126: Bharat Biotech Ltd. - Key offerings
Exhibits 127: CanSino Biologics Inc. - Overview
Exhibits 128: CanSino Biologics Inc. - Product/Service
Exhibits 129: CanSino Biologics Inc. - Key offerings
Exhibits 130: CSL Ltd. - Overview
Exhibits 131: CSL Ltd. - Business segments
Exhibits 132: CSL Ltd. - Key news
Exhibits 133: CSL Ltd. - Key offerings
Exhibits 134: CSL Ltd. - Segment focus
Exhibits 135: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 136: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibits 137: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 138: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 139: Emergent BioSolutions Inc. - Overview
Exhibits 140: Emergent BioSolutions Inc. - Product/Service
Exhibits 141: Emergent BioSolutions Inc. - Key news
Exhibits 142: Emergent BioSolutions Inc. - Key offerings
Exhibits 143: GlaxoSmithKline Plc - Overview
Exhibits 144: GlaxoSmithKline Plc - Business segments
Exhibits 145: GlaxoSmithKline Plc - Key news
Exhibits 146: GlaxoSmithKline Plc - Key offerings
Exhibits 147: GlaxoSmithKline Plc - Segment focus
Exhibits 148: Johnson and Johnson Services Inc. - Overview
Exhibits 149: Johnson and Johnson Services Inc. - Business segments
Exhibits 150: Johnson and Johnson Services Inc. - Key news
Exhibits 151: Johnson and Johnson Services Inc. - Key offerings
Exhibits 152: Johnson and Johnson Services Inc. - Segment focus
Exhibits 153: Merck and Co. Inc. - Overview
Exhibits 154: Merck and Co. Inc. - Business segments
Exhibits 155: Merck and Co. Inc. - Key news
Exhibits 156: Merck and Co. Inc. - Key offerings
Exhibits 157: Merck and Co. Inc. - Segment focus
Exhibits 158: Novavax Inc. - Overview
Exhibits 159: Novavax Inc. - Product/Service
Exhibits 160: Novavax Inc. - Key offerings
Exhibits 161: Panacea Biotec Ltd. - Overview
Exhibits 162: Panacea Biotec Ltd. - Product/Service
Exhibits 163: Panacea Biotec Ltd. - Key offerings
Exhibits 164: Pfizer Inc. - Overview
Exhibits 165: Pfizer Inc. - Product/Service
Exhibits 166: Pfizer Inc. - Key news
Exhibits 167: Pfizer Inc. - Key offerings
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global vaccine research market: Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Creative Biogene.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is adoption of ai to speed up R and D of vaccines.'

According to the report, one of the major drivers for this market is the high prevalence of infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • CanSino Biologics Inc.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Moderna Inc.
  • Novavax Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Creative Biogene